Researchers report evidence that statin use is linked to a lower risk of dementia. The Guardian Health describes findings from a long-term research effort suggesting dementia risk could be reduced by up to 15%, with greater potential benefit when statins are started earlier in life. The outlet also notes broader public-health context, including projections that the number of people living with dementia globally could nearly triple by 2050, and that many cases may be preventable or delayed.
Times of India focuses on a Danish study involving more than 132,000 people, reporting that statins may be associated with reduced dementia risk among people with diabetes. The analysis indicates that beginning statin therapy soon after a diabetes diagnosis may provide the strongest association with benefit. Both outlets emphasize that further research is needed to confirm the extent and mechanisms of any direct protective effect on dementia, rather than effects related to cardiovascular risk reduction.
